8-KLeadership ChangesRegulation FDExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (May 14, 2025)

Filed May 14, 2025For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) announced significant leadership changes via an 8-K filing on May 13, 2025. Effective May 12, 2025, CEO Andrew Witty has stepped down, transitioning to a senior advisor role. Concurrently, the Board of Directors appointed Steve Hemsley, currently the Chair of the Board, as the new Chief Executive Officer. This transition marks a pivotal moment for the company, with a new leader at the helm to guide its future strategic direction. Investors will be keenly interested in Mr. Hemsley's compensation package, which includes a substantial one-time equity award of $60 million in stock options, vesting after three years. While he will not receive an annual cash incentive, his base salary is set at $1 million. The filing also outlines severance benefits, including salary continuation and continued option vesting, contingent on a non-compete agreement. The press release, also furnished, likely provides further context on these changes and their implications for the company's outlook.

Key Highlights

  • 1Andrew Witty has stepped down as CEO, effective May 12, 2025, and will serve as a senior advisor.
  • 2Steve Hemsley has been appointed as the new CEO, effective May 12, 2025, and will continue as Chair of the Board.
  • 3Mr. Hemsley's compensation includes a $1,000,000 annual base salary and no annual cash incentive.
  • 4A one-time equity award of $60,000,000 in nonqualified stock options, with three-year cliff vesting, has been granted to Mr. Hemsley.
  • 5Severance benefits for Mr. Hemsley include two times annual base salary and bonus, with continued option vesting for 24 months, contingent on a non-compete clause.
  • 6The company issued a press release on May 13, 2025, detailing these management changes and earnings guidance.

Frequently Asked Questions